FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080365 [Registered on: 12/02/2025] Trial Registered Prospectively
Last Modified On: 10/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To compare the effect of Dexmedetomidine versus Ketamine nebulization as a premedication on Preoperative anxiety and Post operative agitation in Pediatric patients undergoing Tonsillectomy surgery: A Randomized controlled trial 
Scientific Title of Study   To compare the effect of Dexmedetomidine and Ketamine nebulization as premedication to reduce the Preoperative anxiety and Post operative agitation in Pediatric patients undergoing Tonsillectomy surgery: A Randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shailja Bais 
Designation  Junior Resident 
Affiliation  Institute Of Medical Sciences,BHU,Varanasi 
Address  Department of Anaesthesiology,Sir sunderlal Hospital,Institute of Medical Sciences,BHU,Varanasi,India pincode: 221005
Not Applicable
Varanasi
UTTAR PRADESH
221005
India 
Phone  09754898775  
Fax    
Email  shailja.bais30@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Anil Prasad Singh 
Designation  Proffesor and Head of department 
Affiliation  Institute Of Medical Sciences,BHU,Varanasi 
Address  Department of Anaesthesiology, Sir sunderlal Hospital,Institute of medical science,BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  9839412975  
Fax    
Email  bhuapsingh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Anil Prasad Singh 
Designation  Proffesor and Head of department 
Affiliation  Institute Of Medical Sciences,BHU,Varanasi 
Address  Department of Anaesthesiology, Sir sunderlal Hospital,Institute of medical science,BHU

Varanasi
UTTAR PRADESH
221005
India 
Phone  9839412975  
Fax    
Email  bhuapsingh@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology, Sir Sunderlal Hospital, Institute of Medical Sciences, BHU, Varanasi, India Pincode: 221005 
 
Primary Sponsor  
Name  Shailja Bais 
Address  Department of Anaesthesiology, Sir Sunderlal Hospital, Institute of Medical Sciences, BHU, Varanasi, Pin- 221005 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrShailja Bais  Sir sunderlal Hospital,Institute of Medical Sciences,BHU,Varanasi  Department of Anaesthesiology
Varanasi
UTTAR PRADESH 
9754898775

shailja.bais30@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute of Medical Sciences BHU  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J353||Hypertrophy of tonsils with hypertrophy of adenoids,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Nebulisation with Dexmedetomidine   As premedication to reduce the preoperative anxiety and post operative agitation in pediatric patients undergoing tonsillectomy surgery, they will receive Nebulized Dexmedetomidine with 2 microgram/kilogram dose. Study drugs will be diluted in 3 ml of 0.9% normal saline and will be administered by standard hospital pediatric nebulizer mask via a mouthpiece with a continuous flow of 100% oxygen at 6 L/min for 10-15 min until the solution is empty. The patient will be kept calm by keeping in lap of mother if possible or in the bed if cooperative to receive the nebulization. The attending anesthesiologist, data collection personnel and the patient will be blinded to the study. Each patient had to complete the three phases of the study: preoperative phase (30 min after end of administration of nebulizer study drug), intra operative phase, and the early postoperative phase (1 hour after operation) 
Comparator Agent  Nebulisation with Ketamine  As premedication in a nebulized dose of 2 miligram/kilogram to reduce the preoperative anxiety and post operative agitation in pediatric patients undergoing tonsillectomy surgery. Study drugs will be diluted in 3 ml of 0.9% normal saline and will be administered by standard hospital pediatric nebulizer mask via a mouthpiece with a continuous flow of 100% oxygen at 6 L/min for 10-15 mins until the solution is empty. The patient will be kept calm by keeping in lap of mother if possible or in the bed, if cooperative to receive the nebulization. The attending anesthesiologist, data collection personnel and the patient will be blinded to the study. Each patient had to complete the three phases of the study: preoperative phase (30 min after end of administration of nebulizer study drug), intra operative phase, and the early postoperative phase (1 h after operation) 
 
Inclusion Criteria  
Age From  3.00 Year(s)
Age To  10.00 Year(s)
Gender  Both 
Details  1) ASA I or ASA II physical state
2) Written consent by Parent or Guardian 
 
ExclusionCriteria 
Details  1)Refusal to take part in the study
2)Heart rate below 70 beats per minute.
3)Mean Arterial Pressure less than 70mm of hg
4) Patient with upper respiratory tract infection.
5)Surgery duration longer than 2 Hours.
6)history of allergic reaction to the drugs mentioned in study. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
compare the effect of nebulization with
dexmedetomidine or ketamine as premedication to alleviate preoperative anxiety and
reduce parental separation anxiety for paediatric patients undergoing Tonsillectomy
surgery. 
5,10,20 and 30 minutes 
 
Secondary Outcome  
Outcome  TimePoints 
compare the post operative Emergence Agitation in paediatric patients undergoing Tonsillectomy surgery  60 minutes 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   26/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  26/02/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

INTRODUCTION Preoperative anxiety is common in pediatric patients especially in the age
group of. 3-10 yearuy .Preoperative anxiety can be more harmful, children are more
likely to experience increased autonomic nervous activity compared to adults, leading
to prolonged anesthesia induction time, anesthesia duration, and recovery time. This
1S Complicated further by the psychological characteristics of3 to 10 years old children
are generally more variable, impulsive, and react unintentionally (2). They are aware of
the existence of their parents and are more likely to experience fear and separation
anxiety. In this proposed study, it is intended to address the gap in existing research
by specifically exploring the use of dexmedetomidine and ketamine nebulization for
pediatric patients in Tonsillectomy surgery. The study will assess various parameters,
including hemodynamic changes, sedation levels, parental separation anxiety, mask
acceptance and post operative agitation.
OBJECTIVE AND SCOPE OF THE STUDY
Previously several drugs such as dexmedetomidine, midazolam,
ketamine etc. have been used through different routes (intravenous, intramuscular,
intranasal spray, nebulization) to alleviate the preoperative anxiety (), reduce parental
separation anxiety etc. (6] So, we hypothesize that these drugs in nebulization can be a
useful premedication to alleviate preoperative anxiety and easy parental separation in
paediatric patients, while producing minimal adverse events.
Our plan in this study primarily is to compare the effect of nebulization with
dexmedetomidine or ketamine as premedication to alleviate preoperative anxiety and
-reduce parental separation anxiety for paediatric-patients undergoing Tonsillectomy
surgery and then Secondarily to compare the post operative Emergence Agitation in
this group.
PRELIMINARY WORKALREADY DONE AND COMPLETED:
has
been
done’ and
study protocol
made.
Literature search was
STATEWHETHER ANY WORK PERTAINING TO THE PROPOSED
WORK HAS BEEN IN THE DEPARTMENT EARLIER: no preliminary wok
has been done in the department.
LACUNAE IN KNOWLEDGE OF THE SUBJECT:
The use of dexmedetomidine or ketamine for nebulization as premedication is
been done in previous studies like ketamine, at a dosage of 6 mgkg-l given orally,
reduced the incidence of emergence agitation by 34% in children under anesthesia
with desflurane for adenotonsillectomyuy,but there is no such study done using
Dexmedetomidine or Ketamine nebulization premedication for pediatric patient to
reduce the postoperative emergence agitation as well as preoperative anxiety in
tonsillectomy surgeries. Further, there is no previous literature stating about the
post operative events and mask acceptance for children pre operatively due to these
drugs in pediatric tonsillectomy Surgery.
Inclusion Criteria:
1. Age range 3 to 10 years.
2. ASA I or II physical status
3.Parentguardian’s written consent.
Exclusion criteria:
1. Refusal to take part in the study.
2. Heart rate below 70/min or above 140/min.
3. Mean Arterial pressure less than 70mm of hg.
4. Patient with Upper Respiratory Tract Infection.
5. Surgery duration longer than 2 hours.
6. History of allergic reaction to the drugs mentioned in study.
METHODOLOGY:
The patients fulfilling all the inclusion criteria will be enrolled and will be
divided using Randomized computer generated number which will be sealed in an
opaque envelope technique into two equal groups.
Two study group cach of 36 will be received premedication by nebulization as
follow:
Group K (n=36) will receive nebulized solution ketamine 2 mg kg .
Group D (n-36) will receive nebulized solution dexmedetomidine 2 ug kg.
An independent investigator not involved in the study will open the envelopes 1
hourr before the induction of anesthesia and will prepare the study drug solution as
per the random group. Study drugs will be diluted in 3 ml of 0.9% saline and will
be administered by standard hospital pediatric nebulizer mask via a mouthpiece
with a continuous flow of 100% oxygen at 6 L min for 10-15 min until the
solution is empty. The patient will be kept calm by keeping in lap of mother if
possible or in the bed if cooperative to receive the nebulization. The attending
anesthesiologist, data collection personnel and the patient will be blinded to the
study. Each patient had to complete the three phases of the study: preoperative
phase (30 min after end of administration of nebulizer study drug), intra operative
phase, and the early postoperative phase (1 h after operation).
ASSESSMENT PARAMETERS
Preoperative assessments
The heart rate(HR), non-invasive blood pressure such as systolic blood
pressure(SBP), diastolic blood pressure(DBP), mean arterial blood pressure(MAP),
respiratory rate (RR) and oxygen saturation(SpO2) will be assessed at (0 min i.e.
baseline) and at 5, 10, 20 and 30 min after the end of study drug administration. The
sedation level will be assessed at the same time points mentioned using a five-point
sedation scale score.
At the end of the preoperative phase, parental separation will be assessed by a four
point parental separation anxiety score (PSAS).
1| Agitated; clinging to parent/erying
2 Alert; anxious not clinging to parent, may whimper but not cry
3 Calm; sitting or lying comfortably with eyes open
4| Drowsy; eyes closed but responding to verbal or tactile stimulation
5| Asleep; does not respond to minor stimulation
1Easy separation
2 Whimpers
Cries and not easily reassured but not clinging to parents
4 Crying and clinging to parents
1Excellent; unafraid, cooperative, accepts mask readily
2 Good; slight fear of mask, easily reassured
3 Fair: not calmed with reassurance
4 Poor; terrified; crying or combative
Intraoperative assessments
After arrival in the operating room (0R) all standard monitors such as 12 lead
electrocardiogram (ECG), non-invasive blood pressurc monitor, pulse oximetry will
be attached. An intravenous cannulation of appropriate sizc will be placed and ringer
lactate will be started. Then an appropriate size anesthesia mask will be applied for
Dreoxygenation. The patient’s acceptance of the mask will be assessed using a four
point mask acceptance score (MAS). The ancsthesia will be started by giving Inj
Midazolam 0.15 mg/Kg, Inj Fentanyl I meg/Kg followed by induction with Inj
Propofol2 mg/kg and muscle relaxant Inj.cistaracurium 0.15 mg/Kg. After adequate
depth of anesthesia and muscle relaxation, appropriate size Endotracheal Tube fixed
at Midline to secure the ventilation will be confirmed by EtCo2 monitor. The intra
operative anaesthesia will be maintained by inhalation isoflurane, nitrous oxide and
Oxygen with intermittent doses of Inj cisatracurium and Inj fentanyl.
Mask Acceptance Score (MAS)
The hemodynamic vitals as mentioned in preoperative phase will be recorded intra
operatively at (0 min i.e., baseline) and at every five minutes till the end of surgery.
Early postoperative assessment
The recovery will be assessed using the three-point emergence agitation (EA) score:
The post operative sedation level will be assessed previously using a five
point sedation scale score immediately after extubation and the time required
in min to achieve the score of3.
The haemodynamic vitals will be recorded after admission to the Post
Anaesthesia Care Unit (PACU)at (0 min i.e., baseline) and at 15, 30, 45, and
60 min thereafter.6
Emergence agitation score (EAS)
1 Calm
2 Restless but calms to verbal instructions
3 Combative and disoriented
SCORE CATEGORY
DESCRIPTION
7
Dangerous agitation
Pulling off tracheal tube, trying to remove catheters,
climbing over bedrail, striking the staff
6
Very agitated
Requiring restrain and frequent verbal reminding of
limits.
Agitated
Anxious or mildly agitated, attempting to sit up and
calms down on instructions
4
Calm, cooperated
Calms and follows commands
3
Sedated
Difficult to arouse but awakens to verbal stimuli or
gentle shaking but drifts off again; follows simple
commands.
2
Very sedated
Arouse to physical stimuli but does not communicate or
follow commands; may move spontaneously.
Unarousable
Minimal or no response to noxious stimuli; does not
communicate or follow commands.
Riker Sedation-Agitation Scale (SAS)
Guidelines for SAS Assessment(]
1. Agitated patients are scored by their most severe degree of agitation as
described
2. If patient is awake or awakens easily to voice (awaken means responds
with voice or head shaking to a question or follows commands), that’s a SAS
4 (same as calm and appropriate - might even be napping)
3. If more stimuli such as shaking is required but patient eventually does
awaken, that’s SAS 3
4. If patient arouses to stronger physical stimuli (may be noxious) but never
awakens to.the point of responding yes/no or following commands, that’s a
SAS 2.
5. Little or no response to noxious physical stimuli represents a SAS1. This
helps separate sedated patients into those you can eventually wake up (SAS
3) those yoç can’t awaken but can arouse (SAS 2), and those you can"t arouse
(SAS 1)
STATISTICAL EVALUATION
The obtained data shall be recorded &result shall be statistically analyzed
by appropriate statistical method. A p value of 0.05 will be considered as
significant &<0.01 will be considered as highly significant
The sample size formula of two independent proportions as given below has been
used by taking 10% level of significance and 90% power.
4 = (Z1-/z + Z,-)P(-P) +pa(1-P)
Where Z1-a/2=1.96 at 10% level of significance
Z1-b = 1.282 at 90% power
P1 = proportion improved in dexmedetomidine group 0.47
Q1-1-p1
Qz-1-p2
The sample size thus calculated is n=32 further assuming 10% loss to follow up the
required sample size for present study will be 36 in each group.
REFERENCES: -
1. Kain Z. N, Caldwell- Andrews A..A. Maranets 1. et al. Preoperative anxiety and
emergence delirium and post operative maladaptive behaviors.
AnesthAnalg. 2004; 99:1648-1654
2. Zanaty O.M. Metainy E.L. SA. A comparative evaluation of nebulized
dexmedetomidine, nebulized ketamine, and their combination as premedication
for outpatient paediatric dental surgery AnesthAnalg 2015;121:167-171
3. Abdel- Ghaffar HS. Kamal SM, EI sherif FA, et al. comparision of nebulized
dexmedetomidine, ketamine or midazolam for premedication in preschool
children undergoing bone marrow biopsy, Br J Anaeshth. 2018; 121(2):445-452
4. Hosey MT, Asbury AJ, Bowman AW, Millar K, Martin K, Musiello T, Welbury
R. The effect of transmucosal 0.2 mg/kg midazolam premedication on dental
anxiety, anaesthetic induction and psychological morbidity in children
undergoing general anaesthesia for tooth extraction. Br Dent J. 2009;207:E2
5. Kain ZN, Caldwell-Andrews AA, Maranets I, McClain B, Gaal D, Mayes LC,
Feng R, Zhang H. Preoperative anxiety and emergence delirium and postoperative
maladaptive behaviors. AnesthAnalg. 2004;99:1648-54
6. Irola T, Vilo S, Manner T, Aantaa R, Lahtinen M, Scheinin M, Olkkola KT.
Bioavailability of dexmedetomidine after intranasal administration. Eur J Clin
Pharmacol. 2011;67:825-31
7. Yang X, Hu Z, Peng F, Chen G, Zhou Y, Yang Q, Yang X, Wang M. Effects of
Dexmedetomidine on Emergence Agitation and Recovery Quality Among Children
Undergoing Surgery Under General Anesthesia: A Meta-Analysis of Randomized
Controlled Trials. Front Pediatr. 2020 Nov 13;8:580226. doi:
10.3389/fped.2020.580226. PMID: 33304867; PMCID: PMC7694572.
8. Mortensen M, McMullin C. Discharge score for surgical outpatients. Am J
Nurs.1986;86:1347--9
9. Qiao, H., Xie, Z. & Jia, J. Pediatric premedication: a double-blind randomízed
tria! of dexmedetomidine or ketamine alone versus a combination of
dexmedetomidine and ketamine. BMC Anesthesiol 17, 158 (2017)
t0.K. Jonkman, A. Duma, M. Velzen, A. Dahan; Ketamine inhalation, BJA: British
Journal of Anaesthesia, Volume 118, Issue 2, February 2017, Pages 268-269
11.Kararnmaz A, Kaya S, Turhanoglu S, Ozyilmaz MA. Oral ketamine premedication can prevent
emergence agitation in children after desflurane anaesthesia. PaediatrAnaesth. 2004
Jun;14(6):477-82. doi: 10.1111/j.1460-9592.2004.01224.x. PMID: 151532 10.
0 COMPARE THE EFFECT OF DEXMEDETOMIDINE AND KETAMINE NEBULIZATION
AS PREMEDICATION TO REDUCE THE PREOPERATIVE ANXIETY AND POST OPERATIVE
AGITATION IN PEDIATRIC PATIENTs UNDERGOING TONSILLECTOMY SURGER Y: A
RANDOMIZED CONTROLLED TRIAL"
Signature of HOD:
Signature of Guide:
Signature of Candidate:
Signature of D.R.C members:
1.
2.
3.
4.
5.
CONSENT FORM
Introdoction:
You are requested to participate in a study "A comparative evaluation of nebulization with
dexmedetomidine and ketamine as premedication for paediatrie patients undergoing tonsillectomy
surgery. Your participation in this study is voluntary. You may refuse to participate or withdraw
from the study at any time without this affecting in anyway the medical treatment that you are
receiving. Please read this consent form thoroughly and ask the consultant any questions you may
have about the study before signing.
Explanation of procedures:
If you agree to participate in this study, we will either nebulizer the patient by ketamine 2
mg kg (Group K), or dexmedetomidine 2 ug kg (Group D). We will observe the effect of the
drug used in premedication to alleviate preoperative anxiety and improve cooperation during mask
application in pediatric patients, while producing minimal adverse events. Data from the study will
be used for research purpose and for your treatment. You will be made the data available relevant
to your medical care only and not all the results. You will bear no expenses for your participation
in this study.
Potential benefits:
Your participation will help us to know effects of ketamine 2 mg kg and
dexmedetomidine 2 ug kgfor premedication in paediatric population undergoing tonsillectomy
procedure. The result of this study will be beneficial for the paediatric patients undergoing such
procedure.
Assurance of confidentiality:
The infomation concerning your participation in this study will be kept confidential to the
full extent permitted by law and will be used only for scientific purpose. None, except the members
of the research team will have access to the test results. Your name will not be used in any report
or released in any way.
Parent/Guardian’s Consent:
I have read the explanation about this study and have been given the opportunity to
discuss it and to ask questions. I hereby consent to take part in the study.
Signature of Parent/Guardian
Date.. ...
Signature of witness
Date.
aRE.....
ee....
Aypendix
PROFORMA
DEMOGRAPHIC DATA
NAME
AGE/GENDER
M.R.D. NUMBER
WEIGHT
ASA PHYSICAL STATUS
DATE OF SURGERY
GROUP
Hemodynamic Parameters; Preoperative:
Parameters
TO(min) T5(min)
T10(min) T20(min) T30(min)
Systolic
BP(SBP)
Diastolic
BP(DBP)
Mean BP(MAP)
Heart Rate(HR)
Respiratory
Rate(RR)
Oxygen
Saturation(Spo2)
TO(min)- At the time of starting nebulisation
TS(min)- Smin After the nebulisation
T10(min)-1Omin After the nebulisation
T20(min)-20min After the nebulisation
T30(min)-3Omin After the nebulisation
1-Agitated; clinging to parent/crying
2=Alert; anxious not clinging to parent, may
whimper but not cry
3= Calm; sitting or lying comfortably with
eyes open
4= Drowsy; eyes closed but responding to
verbal or tactile stimulation
5=Asleep; does not respond to minor
stimulation
Five-point sedation score:
Parental separation anxiety score: PSAS
1= Easy separation
2= Whimpers
3= Cries and not easily reassured but not
clinging to parents
4= Crying and clinging to parents
Intraoperative assessments:
Mask acceptance score: MAS
1= Excellent;, unafraid, cooperative, accepts
mask readily
2= Good; slight fear of mask, easily
reassured
3= Fair: not calmed with reassurance
4- Poor; terrified; crying or combative
Hemodynamic Parameters:
Parameters TO(min) TS(min) T10(min) T15(min) T20(min) T25 (min) T30(min)
Systolic
BP (SBP)
Diastolic
BP (DBP)
Mean BP
(MAP)
Heart Rate
(HR)
Respiratory Rate (RR)
Oxygen
Saturation
(Spo2)
TO= At the time of starting of general anaesthesia
T5= Smin after the induction of general anaesthesia
T10= 10 min after the induction of general anaesthesia
T15= 15 min after the induction of general anaesthesia
T20= 20 min after the induction of general anaesthesia
T25=25 min after the induction of general anaesthesia
T30=30 min after the induction of general anaesthesia
Early Post operative assessment:
Post operative sedation score: POSS
l=Agitated; clinging to parcnt/crying
2=Alert; anxious not clinging to parent, may
whimper but not cry
3=Calm; sitting or lying comfortably with
eyes open
4= Drowsy; eyes closed but responding to
verbal or tactile stimulation
5=Asleep; does not respond to minor
stimulation
Time required to achieve POSS of 3 (in minutes):
Hemodynamic Parameters:
Parameters TO(min)
T15(min) T30(min)
T45(min) T60(min)
Systolic
BP(SBP)
Diastolic BP
(DBP)
Mean BP
(MAP)
Heart Rate
(HR)
Respiratory
Rate (RRO
Oxygen Saturation
(SPo2)
T0- At the time of admission to the Post Anesthesia Care Unit
T15- 15 min after the.admission to the Post Anesthesia Care Unit
T30- 30 min after the admission to the Post Anesthesia Care Unit
T45- 45 min after the admission to the Post Anesthesia Care Unit
T60- 60 min after the admission to the Post Anesthesia Care Unit

 
Close